Simon Pedder, Chief Executive Officer at Chelsea Therapeutics International, Ltd. (CHTP), bought 1,250 shares at $4.08 ($5K) on 2010-09-02, disclosed to the SEC on 2010-09-07.
Open-market purchase of $5k CHTP by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ATNX | BUY | 2018-11-14 | $30K | — | Filing → |
| ATNX | BUY | 2017-07-28 | $11K | — | Filing → |
| CLRB | BUY | 2014-08-22 | $50K | — | Filing → |